Precigen (PGEN) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Precigen (PGEN) over the last 14 years, with Q3 2025 value amounting to $171.3 million.

  • Precigen's Liabilities and Shareholders Equity rose 10517.05% to $171.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $547.2 million, marking a year-over-year increase of 2365.72%. This contributed to the annual value of $145.3 million for FY2024, which is 382.47% down from last year.
  • Latest data reveals that Precigen reported Liabilities and Shareholders Equity of $171.3 million as of Q3 2025, which was up 10517.05% from $101.9 million recorded in Q2 2025.
  • In the past 5 years, Precigen's Liabilities and Shareholders Equity ranged from a high of $407.0 million in Q1 2021 and a low of $73.2 million during Q2 2024
  • Over the past 5 years, Precigen's median Liabilities and Shareholders Equity value was $207.5 million (recorded in 2023), while the average stood at $226.7 million.
  • Per our database at Business Quant, Precigen's Liabilities and Shareholders Equity plummeted by 6474.68% in 2024 and then surged by 10517.05% in 2025.
  • Precigen's Liabilities and Shareholders Equity (Quarter) stood at $359.9 million in 2021, then plummeted by 39.98% to $216.0 million in 2022, then tumbled by 30.07% to $151.0 million in 2023, then decreased by 3.82% to $145.3 million in 2024, then increased by 17.9% to $171.3 million in 2025.
  • Its Liabilities and Shareholders Equity was $171.3 million in Q3 2025, compared to $101.9 million in Q2 2025 and $128.8 million in Q1 2025.